High Cholesterol Ups Risk of Aggressive Prostate Cancer

High Cholesterol Ups Risk of Aggressive Prostate Cancer

High cholesterol levels are associated with an increased short-term risk of prostate cancer (PCa), particularly aggressive PCa, according to a new study. Long-term risk,...

Prostate Cancer ADT Linked to Higher Risk of Liver Diseases

Prostate Cancer ADT Linked to Higher Risk of Liver Diseases

Men who undergo androgen deprivation therapy (ADT) for prostate cancer (PCa) are at elevated risk of developing non-alcoholic fatty liver disease and other liver diseases, a...

Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer

Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer

Urine cytology provides no added benefit when evaluating hematuria as part of a diagnostic workup for bladder cancer or upper tract urothelial cancer (UTUC) and should not be...

Statin Plus Metformin May Reduce Prostate Cancer Relapse Risk

Statin Plus Metformin May Reduce Prostate Cancer Relapse Risk

Concomitant use of statins and metformin may decrease a prostate cancer (PCa) patient's risk of biochemical recurrence (BCR) following radical prostatectomy compared with the...

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

ORLANDO—Adding short-term androgen deprivation therapy (STADT) to radiotherapy does not improve overall survival (OS) among men with intermediate-risk prostate cancer (IRPC),...

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding 6 months of androgen deprivation therapy (ADT) to radiotherapy for localized prostate cancer (PCa) decreases the risk of biochemical progression, according to study data...

Prostate Cancer Recurrence After Surgery Linked to High Lipids

Prostate Cancer Recurrence After Surgery Linked to High Lipids

Elevated triglyceride levels are associated with an increased risk of prostate cancer (PCa) recurrence after radical prostatectomy (RP), according to a recent study. In a...

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

ORLANDO, Fla.—Adding statins to androgen-deprivation therapy (ADT) may improve survival among men who experience biochemical recurrence of prostate cancer (PCa) following...

Low Testosterone After ADT Linked with Improved Survival

Low Testosterone After ADT Linked with Improved Survival

Low serum testosterone levels within the first year of androgen-deprivation therapy (ADT) in men with castration-resistant prostate cancer (PCa) undergoing continuous androgen...

Adding Statins to ADT May Delay PCa Progression

Adding Statins to ADT May Delay PCa Progression

ORLANDO, Fla.—Taking a statin during treatment with androgen deprivation therapy (ADT) might lengthen the time before a prostate cancer (PCa) becomes resistant, according to new...

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding 6 months of androgen deprivation therapy (ADT) to radiotherapy for localized prostate cancer (PCa) decreases the risk of biochemical progression, according to study data...

Adding Statins to ADT May Delay PCa Progression

Adding Statins to ADT May Delay PCa Progression

ORLANDO, Fla.—Taking a statin during treatment with androgen deprivation therapy (ADT) might lengthen the time before a prostate cancer (PCa) becomes resistant, according to new...